MYOM2 and myasthenia gravis: Moreover, the M-protein has known thrombogenic properties that have a proven causative relationship with thrombotic events, and have been described in otherwise asymptomatic MGUS patients or in patients with MG not fulfilling treatment criteria [10,11].